3rd Health Programme (2014-2020)
High-quality blood stem cells products available for all patients in need, and to protect the rights and welfare of volunteer stem cell donors [SAVDON]
Annually more than 20,000 volunteer unrelated blood stem cell donations are undertaken. Living donors donate their cells for patients in need of a transplant. The EU plays an important role in the pro...
Annually more than 20,000 volunteer unrelated blood stem cell donations are undertaken. Living donors donate their cells for patients in need of a transplant. The EU plays an important role in the provision of these products. In 2016 the EU countries provided 6,817 blood stem donations internationally and 3,194 donations were provided nationally.
WMDA plays a key role in the international exchange of blood stem cell products by providing a search tool for healthcare professionals and by setting standards for international exchange. In order to harmonise international exchange and speed up the logistics of the search process WMDA is applying for a Framework Partnership Agreement with the EU.
Volunteers have the right to receive accurate information about their risks to donate their blood stem cells. Since 2002 donor safety has become a highly visible issue. In that time WMDA has started up a reporting system for adverse events and reactions. It is important to reassure potential donors that there are systems in place to protect them from adverse outcomes and that there is a continuous learning system which is informed by global reporting. The next step is to collaborate with regulatory authorities in order to improve dissemination.
In the area of import from third countries it is important to harmonise and to collaborate between EU Member States. At the moment 14% of the adult volunteer donations and 30% of the cord blood products are imported from third countries. To avoid delay for patients waiting on their transplant information needs to be available that can be shared between Competent Authorities and healthcare professionals facilitating searches.
The current ICT infrastructure to support the search process and request for a donation is delaying adequate treatment for patients. Innovation of the ICT infrastructure will help physicians to find a donor with a few clicks in the database.
This proposal describes how WMDA and EU can collaborate from 2018-2021.
Start date: 11/04/2018 - End date: 10/04/2022
Call: Operating grants 2018-2021
Topic: Substance Of Human Origin